IN VIVO ENDOTHELIAL INJURY AND DEPENDENT VASOMOTION
IN VIVO ENDOTHELIAL INJURY AND DEPENDENT VASOMOTION
批准号:
3356993
负责人:
JAMES H CHESEBRO
金额:
$19.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-30 至 1991-07-31
关键词:
acetylcholine angiography atherosclerosis cholesterol coronary disorder dietary lipid heart pharmacology human subject intraluminal angioplasty myocardial infarction nutrition related tag pathogenic diet radiotracer tissue /cell culture vascular endothelium vasoactive agent vasoconstriction vasodilation
中文摘要
内皮依赖性血管舒张功能受损
(EDVR)在体内冠状动脉中可能与
部分由冠状动脉风险引起的内皮损伤量
因素和动脉粥样硬化的猪和病人,
降低风险因素。 动脉血管收缩可以
减少血流量,增加动脉壁剪切力,
增加血小板在受损动脉中的沉积,
动脉粥样硬化斑块的突然破裂。 内皮
可以代谢和减少壁内扩散
管腔内血管收缩物质(血小板产物和
儿茶酚胺),防止血小板活化和随后的
释放血小板血管收缩物质,并促进
通过前列环素的产生和释放进行血管舒张,
内皮源性舒张因子(EDRF)。
在猪中,我们将检验节段性冠状动脉
EDVR的动脉损害(通过定量测量)
血管造影),以乙酰胆碱(EDRF-
释放剂)与内皮损伤的程度相关
(通过111 In标记的自体血小板的程度来定量
沉积(血小板数量/立方厘米)和表面的百分比
伊文思蓝染色区域)(a)由轻度球囊扩张诱导,
(B,c)内皮样细胞再生长4天和8天后
球囊损伤后,(d)通过4个月的2%胆固醇喂养诱导
(e)4个月后愈合或内皮再生后
停止胆固醇喂养,(f)8个月4%诱导
胆固醇喂养,在近端,覆盖,和远端的位置
大于50%的动脉粥样硬化病变,和(g)4个月后
停止4%胆固醇喂养。
EDVR的节段性冠状动脉损害
(通过定量冠状动脉造影测量)至分级
乙酰胆碱的输注可以作为研究
内皮损伤的严重程度(以及
愈合或再生长)在最小病变的冠状动脉中
在(a)降低升高的甘油三酯和
胆固醇,(B)降低升高的胆固醇,和(c)
戒烟。 节段性冠状动脉损伤
EDVR也可以是用于测量时间和程度的探针,
球囊部位近端和远端的内皮愈合
血管成形术(存在内皮损伤但无平滑
肌肉细胞坏死),在产瘤动脉中,
心肌梗死或不稳定型心绞痛,以及用于确定
冠状动脉危险因素的最佳降低水平
内皮的愈合。
英文摘要
The impairment of endothelial-dependent vascular relaxation
(EDVR) in vivo in coronary arteries is probably related to the
amount of endothelial injury induced in part by coronary risk
factors and atherosclerosis in pigs and patients and may be
reduced by risk factor reduction. Vasoconstriction in arteries can
reduce blood flow, increase arterial wall-shear forces which
increases platelet deposition in injured arteries, and may
precipitate rupture of atherosclerotic plaques. The endothelium
can metabolize and reduce the intramural diffusion of
intraluminal vasoconstrictive substances (platelet products and
catecholamines), prevent platelet activation and subsequent
release of platelet vasoconstrictive substances, and promote
vasodilation via the production and release of prostacyclin and
endothelial-derived relaxing factor (EDRF).
In the pig, we will test the hypothesis that the segmental coronary
arterial impairment of EDVR (measured by quantitative
angiography) to graded infusions of acetycholine (an EDRF-
releasing agent) correlates with the extent of endothelial injury
(quantitated by the degree of 111 In-labeled autologous platelet
deposition (no. of platelets/cubic cm.) and the percent of surface
area stained by Evans blue) (a) induced by mild balloon dilatation,
(b, c) following regrowth of endothelial-like cells 4 and 8 days
after balloon injury, (d) induced by 4 mo of 2% cholesterol feeding
(e) following healing or regrowth of endothelium after 4 mo
withdrawal of cholesterol feeding, (f) induced by 8 mo of 4%
cholesterol feeding, in locations proximal, overlying, and distal to
a greater than 50% atherosclerotic lesion, and (g) 4 mo after
withdrawal from 4% cholesterol feeding.
In patients segmental coronary arterial impairment of EDVR
(measured by quantitative coronary angiography) to graded
infusions of acetylcholine can be a probe to investigate the
severity of endothelial injury (and the extent and timing of
healing or regrowth) in minimally diseased coronary arteries
before and after (a) reduction of elevated triglycerides and
cholesterol, (b) reduction of elevated cholesterol, and (c)
cessation of smoking. Segmental coronary arterial impairment of
EDVR can also be a probe for measuring the timing and degree of
endothelial healing just proximal and distal to the site of balloon
angioplasty (where there is endothelial damage but no smooth
muscle cell necrosis), in the symptom-producing artery after
myocardial infarction or unstable angina, and for determining the
level of coronary risk factor reduction necessary for optimal
healing of the endothelium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLOPIDOGREL DOSING IN HUMAN ARTERIAL THROMBUS FORMATION
-
批准号:6305206
-
项目类别:
-
资助金额:$4.76万
-
财政年份:1999
-
负责人:JAMES H CHESEBRO
-
依托单位:
CLOPIDOGREL DOSING IN HUMAN ARTERIAL THROMBUS FORMATION
-
批准号:6264363
-
项目类别:
-
资助金额:$4.76万
-
财政年份:1998
-
负责人:JAMES H CHESEBRO
-
依托单位:
ANTITHROMBOTIC EFFECT OF ESCALATING DOSES OF PEG HIRUDIN IN HUMANS
-
批准号:6276353
-
项目类别:
-
资助金额:$6.67万
-
财政年份:1997
-
负责人:JAMES H CHESEBRO
-
依托单位:
LIPID LOWERING WITH SIMVASTATINE AFTER ACURE CORONARY SYNDROMES
-
批准号:6246268
-
项目类别:
-
资助金额:$4.47万
-
财政年份:1997
-
负责人:JAMES H CHESEBRO
-
依托单位:
CARDIAC PROTEINS AND AUTOANTIBODIES IN MYOCARDIAL INFARCTION
-
批准号:6246260
-
项目类别:
-
资助金额:$4.47万
-
财政年份:1997
-
负责人:JAMES H CHESEBRO
-
依托单位:
ANTITHROMBOTIC EFFECT OF ESCALATING DOSES OF PEG HIRUDIN IN HUMANS
-
批准号:6246281
-
项目类别:
-
资助金额:$4.47万
-
财政年份:1997
-
负责人:JAMES H CHESEBRO
-
依托单位:
LIPID LOWERING WITH SIMVASTATINE AFTER ACURE CORONARY SYNDROMES
-
批准号:6276345
-
项目类别:
-
资助金额:$6.67万
-
财政年份:1997
-
负责人:JAMES H CHESEBRO
-
依托单位:
SAFETY, PHARMACOKINETIC/PHARMACODYNAMIC EFFECT OF PEG HIRUDIN ON ANTICOAGULATION
-
批准号:6276372
-
项目类别:
-
资助金额:$6.67万
-
财政年份:1997
-
负责人:JAMES H CHESEBRO
-
依托单位:
IN VIVO ENDOTHELIAL INJURY AND DEPENDENT VASOMOTION
-
批准号:3356996
-
项目类别:
-
资助金额:$19.32万
-
财政年份:1987
-
负责人:JAMES H CHESEBRO
-
依托单位:
IN VIVO ENDOTHELIAL INJURY AND DEPENDENT VASOMOTION
-
批准号:3356994
-
项目类别:
-
资助金额:$21.96万
-
财政年份:1987
-
负责人:JAMES H CHESEBRO
-
依托单位:
IN VIVO ENDOTHELIAL INJURY AND DEPENDENT VASOMOTION
-
批准号:3356995
-
项目类别:
-
资助金额:$23.32万
-
财政年份:1987
-
负责人:JAMES H CHESEBRO
-
依托单位:
CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCATION
-
批准号:3660106
-
项目类别:
-
资助金额:$31.59万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCATION
-
批准号:3660109
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
PLATELET INHIBITOR DRUG TRIAL IN CORONARY ANGIOPLASTY
-
批准号:3342044
-
项目类别:
-
资助金额:$28.09万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCATION
-
批准号:3660107
-
项目类别:
-
资助金额:$15.02万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCATION
-
批准号:3660105
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCATION
-
批准号:3660103
-
项目类别:
-
资助金额:$30.78万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
PLATELET INHIBITOR DRUG TRIAL IN CORONARY ANGIOPLASTY
-
批准号:3342043
-
项目类别:
-
资助金额:$31.61万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
PLATELET INHIBITOR DRUG TRIAL IN CORONARY ANGIOPLASTY
-
批准号:3342042
-
项目类别:
-
资助金额:$28.26万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCATION
-
批准号:3660111
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1983
-
负责人:JAMES H CHESEBRO
-
依托单位:
海外基金